White IN - Search Results

1

Greaves P, White IN. Greaves P, et al. Among authors: white in. Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):503-10. doi: 10.1016/j.bpobgyn.2006.01.003. Epub 2006 Feb 23. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16500151 Review.

2

Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.

Green AR, Styles JA, Parrott EL, Gray D, Edwards RE, Smith AG, Gant TW, Greaves P, Al-Azzawi F, White IN. Green AR, et al. Among authors: white in. Exp Toxicol Pathol. 2005 Mar;56(4-5):255-63. doi: 10.1016/j.etp.2004.10.001. Exp Toxicol Pathol. 2005. PMID: 15816354

3

Adenomyosis--a result of disordered stromal differentiation.

Parrott E, Butterworth M, Green A, White IN, Greaves P. Parrott E, et al. Among authors: white in. Am J Pathol. 2001 Aug;159(2):623-30. doi: 10.1016/S0002-9440(10)61733-6. Am J Pathol. 2001. PMID: 11485920 Free PMC article.

4

Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factor-alpha expression in specific neonatal mouse uterine cell types using laser capture microdissection.

Green AR, Edwards RE, Greaves P, White IN. Green AR, et al. Among authors: white in. J Mol Endocrinol. 2003 Feb;30(1):1-11. doi: 10.1677/jme.0.0300001. J Mol Endocrinol. 2003. PMID: 12580757

5

Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol.

Razvi N, Greaves P, Styles J, Edwards R, White IN. Razvi N, et al. Among authors: white in. Exp Toxicol Pathol. 2007 Nov;59(3-4):177-85. doi: 10.1016/j.etp.2007.06.002. Epub 2007 Sep 6. Exp Toxicol Pathol. 2007. PMID: 17825543

6

Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.

Green AR, Parrott EL, Butterworth M, Jones PS, Greaves P, White IN. Green AR, et al. Among authors: white in. J Endocrinol. 2001 Sep;170(3):555-64. doi: 10.1677/joe.0.1700555. J Endocrinol. 2001. PMID: 11524235

7

Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen.

Johnson SM, Maleki-Dizaji M, Styles JA, White IN. Johnson SM, et al. Among authors: white in. Endocr Relat Cancer. 2007 Jun;14(2):337-50. doi: 10.1677/ERC-06-0085. Endocr Relat Cancer. 2007. PMID: 17639049

8

Chemoprevention of breast cancer by tamoxifen: risks and opportunities.

Smith LL, White IN. Smith LL, et al. Among authors: white in. Toxicol Lett. 1995 Dec;82-83:181-6. doi: 10.1016/0378-4274(95)03476-5. Toxicol Lett. 1995. PMID: 8597049 Review.

9

Antiestrogen therapy: uncertainties and risk assessment.

Smith LL, White IN. Smith LL, et al. Among authors: white in. Oncology (Williston Park). 1998 Mar;12(3 Suppl 5):14-22. Oncology (Williston Park). 1998. PMID: 9556786 Free article. Review.

10

Anti-oestrogenic drugs and endometrial cancers.

White IN. White IN. Toxicol Lett. 2001 Mar 31;120(1-3):21-9. doi: 10.1016/s0378-4274(01)00303-4. Toxicol Lett. 2001. PMID: 11323158 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters